Society of Urologic Oncology 25th Annual Meeting 2024
Include: 15 videos + 1 pdf, size: 12.9 GB
Target Audience: urologic oncologists, medical and radiation oncologists
Information:
The Society of Urologic Oncology (SUO)’s mission is to enable qualified members primarily interested in the care of patients with malignant GU diseases to meet for the purpose of discussion, development, and implementation of ideas to improve care. The organization strives to stimulate research and teaching in urologic oncology, disseminate the principles of urologic oncology to the medical profession at large, bring urologists into a society whose work is entirely/principally in malignant disease, be the most qualified organization on matters of urologic oncology, and standardize fellowship training in urologic oncology.
December 4 – 6, 2024
Location: Dallas, Texas
at the Sheraton Dallas Hotel
The 25th Annual Meeting of the Society of Urologic Oncology (SUO 2024) is geared toward a multidisciplinary audience involved in the care and research of genitourinary (GU) malignancies. The primary target audience includes:
- Urologic oncologists
- Medical and radiation oncologists
- Urology residents and fellows
- Academic researchers in GU oncology
- Clinical trialists and translational scientists
- Healthcare professionals involved in prostate, kidney, bladder, and testicular cancer care
The meeting fosters collaboration across specialties and features sessions on clinical research, emerging therapies, and innovations in urologic oncology
Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
- Advanced Disease and Adjuvant Therapy.mp4
Annual Business Meeting, Awards, and NIH Update.mp4
Bladder Cancer Session I.mp4
Bladder Cancer Session II.mp4
Health Services Session.mp4
Kidney Cancer Session I.mp4
Kidney Cancer Session II.mp4
Prostate Cancer Session I.mp4
Prostate Session II.mp4
State of the Art Session I- Smoking Cessation, Vaping & E-Cigarettes.mp4
State of the Art Session II- BCG Unresponsive Non-Muscle Invasive Bladder Cancer – So Many Therapies, How Do We Choose.mp4
SUO-25th-Annual-Meeting-Program-Book.pdf
SUO-Clinical Trials Consortium (SUO-CTC) Session.mp4
Testis Cancer Session.mp4
The Current Controversy of Seminoma.mp4
Young Urologic Oncologists (YUO) Program.mp4
